Gilead to expand sofosbuvir plant days after positive US FDA review
Gilead will spend $47m (Eur 34m) to expand a Canadian plant at which it produces biopharmaceuticals for trials, including its Ph III hep C drug candidate sofosbuvir.
Archives for October 24, 2013
Pall opens Centre of Excellence in Shanghai
Pall has opened of a Centre of Excellence (CofE) in Shanghai for both local and international customers.
Nanotherapeutics to invest $122m to make biologics for US military
Biologics firm Nanotherapeutics has started work on a new facility that will produce biological countermeasures for the US military.